Zhihang Zhou

Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial–mesenchymal transition

Huiqin Quan, Fengfeng Zhou, Dan Nie et al. · Oncogene · 2013 · 140 citations

Life Sciences, Molecular Biology, Oncology +17

A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

Wu‐tong Ju, Ronghui Xia, Dongwang Zhu et al. · Nature Communications · 2022 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis

Zhihang Zhou, Jin‐Wen Song, Wen Li et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 83 citations · Full text

Medicine, Molecular Biology, Oncology +17

GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis

Tianxing Chen, Zhihang Zhou, Haitao Li et al. · Cell Death and Differentiation · 2023 · 71 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)

Yingying Huang, Jingjing Sun, Jun Li et al. · International Journal of Surgery · 2023 · 69 citations · Full text

Medicine, Immunology, Oncology +17